Literature DB >> 12480305

Concentrations of nine alkenylbenzenes, coumarin, piperonal and pulegone in Indian bidi cigarette tobacco.

S B Stanfill1, A M Calafat, C R Brown, G M Polzin, J M Chiang, C H Watson, D L Ashley.   

Abstract

Indian-made bidi cigarettes sold in the United States are available in a variety of exotic (e.g. clove, mango) and candy-like (e.g. chocolate, raspberry) flavors. Because certain tobacco flavorings contain alkenylbenzenes and other toxic or carcinogenic chemicals, we measured the concentration of flavor-related compounds in bidi tobacco using a previously developed method. Twenty-three brands of bidis were sampled using automated headspace solid-phase microextraction and subsequently analyzed for 12 compounds by gas chromatography-mass spectrometry. Two alkenylbenzene compounds, trans-anethole and eugenol, were found in greater than 90% of the brands analyzed. Methyleugenol, pulegone and estragole were each detected in 30% or more of the brands, whereas safrole and elemicin were not detected in any of the brands. The flavor-related compounds with the highest tobacco concentrations were eugenol (12,000 microg/g tobacco) and trans-anethole (2200 microg/g tobacco). The highest eugenol and trans-anethole concentrations found in bidi tobacco were about 70,000 and 7500 times greater, respectively, than the highest levels previously found in US cigarette brands. Measurement of these compounds is crucial to evaluation of potential risks associated with inhaling highly concentrated flavor-related compounds from bidis or other tobacco products.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12480305     DOI: 10.1016/s0278-6915(02)00230-2

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  10 in total

1.  A comparison of US and Norwegian regulation of coumarin in tobacco products.

Authors:  M Givel
Journal:  Tob Control       Date:  2003-12       Impact factor: 7.552

Review 2.  Non-cigarette tobacco products: what have we learnt and where are we headed?

Authors:  Richard J O'Connor
Journal:  Tob Control       Date:  2012-03       Impact factor: 7.552

3.  Biomarkers of Chronic Acrolein Inhalation Exposure in Mice: Implications for Tobacco Product-Induced Toxicity.

Authors:  Daniel J Conklin; Marina V Malovichko; Iris Zeller; Trinath P Das; Tatiana V Krivokhizhina; Blake H Lynch; Pawel Lorkiewicz; Abhinav Agarwal; Nalinie Wickramasinghe; Petra Haberzettl; Srinivas D Sithu; Jasmit Shah; Timothy E O'Toole; Shesh N Rai; Aruni Bhatnagar; Sanjay Srivastava
Journal:  Toxicol Sci       Date:  2017-08-01       Impact factor: 4.849

Review 4.  Tobacco cessation in primary care: maximizing intervention strategies.

Authors:  John D Anczak; Robert A Nogler
Journal:  Clin Med Res       Date:  2003-07

5.  Electronic cigarette-generated aldehydes: The contribution of e-liquid components to their formation and the use of urinary aldehyde metabolites as biomarkers of exposure.

Authors:  Daniel J Conklin; Mumiye A Ogunwale; Yizheng Chen; Whitney S Theis; Michael H Nantz; Xiao-An Fu; Lung-Chi Chen; Daniel W Riggs; Pawel Lorkiewicz; Aruni Bhatnagar; Sanjay Srivastava
Journal:  Aerosol Sci Technol       Date:  2018-08-23       Impact factor: 2.908

6.  Quantitation of Ten Flavor Compounds in Unburned Tobacco Products.

Authors:  Joseph G Lisko; Stephen B Stanfill; Clifford H Watson
Journal:  Anal Methods       Date:  2014       Impact factor: 2.896

7.  Identification of flavour additives in tobacco products to develop a flavour library.

Authors:  Erna Jz Krüsemann; Wouter F Visser; Johannes Wjm Cremers; Jeroen LA Pennings; Reinskje Talhout
Journal:  Tob Control       Date:  2017-02-11       Impact factor: 7.552

8.  Analysis of coumarin and angelica lactones in smokeless tobacco products.

Authors:  Kevin McAdam; Trevor Enos; Carol Goss; Harriet Kimpton; Arif Faizi; Steve Edwards; Christopher Wright; Andrew Porter; Brad Rodu
Journal:  Chem Cent J       Date:  2018-12-20       Impact factor: 4.215

9.  Human consumption of methyleugenol and its elimination from serum.

Authors:  Arnold Schecter; George W Lucier; Michael L Cunningham; Kamal M Abdo; Greg Blumenthal; Andrew G Silver; Ron Melnick; Christopher Portier; Dana B Barr; John R Barr; Stephen B Stanfill; Donald G Patterson; Larry L Needham; Woodhall Stopford; Scott Masten; Jill Mignogna; Kuang Chi Tung
Journal:  Environ Health Perspect       Date:  2004-05       Impact factor: 9.031

Review 10.  Pharmacological and therapeutic effects of Mentha Longifolia L. and its main constituent, menthol.

Authors:  Peyman Mikaili; Sina Mojaverrostami; Milad Moloudizargari; Shahin Aghajanshakeri
Journal:  Anc Sci Life       Date:  2013-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.